Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Sep;22(3):426–430. doi: 10.1128/aac.22.3.426

Activity of metronidazole and its hydroxy and acid metabolites against clinical isolates of anaerobic bacteria.

J P O'Keefe, K A Troc, K D Thompson
PMCID: PMC183761  PMID: 7137984

Abstract

Susceptibility of clinical isolates of anaerobic bacteria to metronidazole and its two oxidation products, 1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole (the "alcohol" metabolite) and 2-methyl-5-nitroimidazole-1-acetic acid (the "acid" metabolite), were determined by the agar dilution technique. Results disclosed that the alcohol metabolite, although less active than metronidazole, inhibited the organisms tested at levels considered susceptible for metronidazole. The acid metabolite was less active, not inhibiting the organisms at levels within the susceptible range. In other studies, mixtures of known concentrations of metronidazole and the metabolites were assayed in a bioassay system used to measure metronidazole levels. These studies showed that the bioassay will measure metronidazole or the alcohol metabolite; the acid metabolite is not measured at levels achieved in clinical specimens. Since the activity of the alcohol metabolite is comparable to that of metronidazole, we feel that microbiological assays can be used for therapeutic monitoring of metronidazole levels in clinical situations.

Full text

PDF
426

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use. Drugs. 1978 Nov;16(5):387–417. doi: 10.2165/00003495-197816050-00002. [DOI] [PubMed] [Google Scholar]
  2. Ingham H. R., Slekon J. B., Roxby C. M. Bacteriological study of otogenic cerebral abscesses: chemotherapeutic role of metronidazole. Br Med J. 1977 Oct 15;2(6093):991–993. doi: 10.1136/bmj.2.6093.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Koch-Weser J., Goldman P. Drug therapy: metronidazole. N Engl J Med. 1980 Nov 20;303(21):1212–1218. doi: 10.1056/NEJM198011203032106. [DOI] [PubMed] [Google Scholar]
  4. Louie T. J., Tally F. P., Bartlett J. G., Gorbach S. L. Rapid microbiological assay for chloramphenicol and tetracyclines. Antimicrob Agents Chemother. 1976 Jun;9(6):874–878. doi: 10.1128/aac.9.6.874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Nilsson-Ehle I., Ursing B., Nilsson-Ehle P. Liquid chromatographic assay for metronidazole and tinidazole: pharmacokinetic and metabolic studies in human subjects. Antimicrob Agents Chemother. 1981 May;19(5):754–760. doi: 10.1128/aac.19.5.754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ralph E. D., Kirby W. M. Bioassay of metronidazole with either anaerobic or aerobic incubation. J Infect Dis. 1975 Nov;132(5):587–591. doi: 10.1093/infdis/132.5.587. [DOI] [PubMed] [Google Scholar]
  7. Wick W. E. In vitro and in vivo laboratory comparison of cephalothin and desacetylcephalothin. Antimicrob Agents Chemother (Bethesda) 1965;5:870–875. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES